Clinical Trial Update: Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab plus chemotherapy after progression on PD-1/PD-L1 in cisplatin-ineligible advanced urothelial carcinoma; study terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Nabil Adra | Conditions: Urothelial Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2023-09-13